Online Psychiatric Care for People Already on Medication: The Continuity Question

Most people who seek online psychiatric care are not starting from scratch.

They are already on medication. Maybe it is working reasonably well. Maybe it worked at some point and they are not sure anymore. Maybe they moved, changed insurance, or lost access to the prescriber who knew their history. Whatever the reason, they are arriving at a new platform with a treatment history and a specific, practical question: will you continue what I am on, or do we have to start over?

The continuity question is not really about prescription refills. It is about something more clinically substantive: whether the new platform can actually take on your care, hold your history, and maintain the kind of ongoing oversight that makes psychiatric medication safe and effective over time. A refill is not continuity. A new prescriber who reviews your full medication history, your current symptom picture, and your treatment trajectory, and then monitors what happens next, is continuity.

The difference matters because being on a medication is not the same as being optimally on a medication. Many people who have been on an antidepressant for a year or more are still at a starting dose, still experiencing side effects their previous prescriber never fully addressed, and still not sure whether the medication is actually doing what it is supposed to do. Genuine continuity gives you a clinical team that can see that picture, evaluate it honestly, and adjust it when the evidence says adjustment is warranted.

Why "Continuing" a Medication Is Not as Simple as It Sounds

SSRIs and SNRIs, the medications most commonly prescribed online for depression and anxiety, are not set-and-forget treatments. They require titration, response monitoring, and periodic reassessment of whether the current dose is producing the intended therapeutic effect. The standard clinical window for a full response assessment is four to eight weeks after reaching a therapeutic dose, with research consistently showing that approximately 50% of patients with major depressive disorder do not adhere to their prescribed regimen, often because no one was checking whether the medication was working or managing side effects in the critical early months.

When you arrive at a new online platform already on an antidepressant, several clinically important questions are unanswered. Is your current dose still appropriate for your current symptom presentation? Have your symptoms changed since the dose was established? Are there side effects that were never fully addressed? Is there a reason your previous prescriber chose this specific medication over alternatives? Does the new prescriber know any of that?

The continuity question is also an access question. According to the 2024 National Survey on Drug Use and Health from SAMHSA, nearly half of U.S. adults with a mental illness received no treatment in the past year. The people who are already on medication and seeking a new platform are, in many cases, the ones who have managed to stay in care despite a fragmented system. Serving them well means not creating a new gap in their coverage while they transition.

Why a New Clinical Evaluation Is Required, Not Optional

This point often surprises established patients: a new prescriber cannot simply confirm your existing prescription without conducting their own clinical evaluation. This is not bureaucratic friction. It is the foundation of responsible prescribing.

A licensed prescriber who approves a medication without reviewing your current clinical presentation has not established the patient-physician relationship that prescribing legally requires. The American Psychiatric Association specifies that telepsychiatry requires conducting a thorough examination and establishing a patient-physician relationship before prescribing, the same standard as in-person care. Continuing a prior prescription without that review is not continuity. It is a refill service with clinical accountability removed.

There is also a practical clinical reason. The prescriber who first put you on your current medication may have had information that is no longer accurate. Your symptoms may have evolved. Your other medications may have changed. Life circumstances that were relevant to your original diagnosis may be different now. A thoughtful evaluation is not starting over. It is making sure the treatment plan you are continuing is actually appropriate for who you are now, not who you were when the prescription was first written.

What the First Appointment Should Cover for Established Patients

For a patient already on psychiatric medication, the first evaluation at a new platform has a specific scope that differs from a first-timer. In addition to standard intake elements, a comprehensive evaluation of an established patient should include:

• Your full medication history: Not just your current prescription, but prior medications you have tried, how they worked, and why you stopped them if you did.
• Your current response: Whether your current medication is actually producing the intended effect, and how you would describe your symptom level now compared to before treatment.
• Side effect history: Side effects that were never fully resolved, and whether your previous prescriber ever adjusted the dose or timing in response to them.
• Current dosing and duration: How long you have been at your current dose, and whether there has ever been an attempt at titration.
• Any changes since your last assessment: Medical conditions, other medications, life circumstances, or symptom patterns that have shifted since your original prescription was written.
• Your treatment goals: What you are hoping care will help you achieve, beyond "not depressed," and whether your current plan is moving you toward those goals.

This evaluation should produce a clinical baseline. That baseline is what makes ongoing monitoring meaningful, because you need a before to have an after.

The Three Factors That Determine Whether Your Transition Goes Well

Intake depth. The quality of your transition depends on how comprehensively the new platform captures your history. An intake that asks about your current symptoms and current medication but skips prior treatment history, side effect patterns, and treatment goals leaves your new prescriber with an incomplete clinical picture. The more complete the intake, the better the clinical foundation for whatever comes next.

Between-visit monitoring. This is where most psychiatric care fails established patients. Being on medication for a year does not mean your medication is still working optimally. Symptoms shift. Sleep patterns change. Anxiety levels fluctuate with life circumstances that a quarterly appointment cannot capture. A platform with structured between-visit monitoring, daily or weekly check-ins that feed clinical data to your prescriber, can catch drift in your symptom trajectory before it becomes a clinical problem. Research published in JMIR Formative Research found that more frequent digital engagement was associated with meaningfully better clinical outcomes in both anxiety and depression over a six-month period. The monitoring structure is not incidental. It is the mechanism by which continuity produces benefit.

Provider continuity. Seeing the same prescriber who holds your full clinical history produces meaningfully different care than cycling through available providers. A 2023 prospective cohort study published in BMC Psychiatry found that higher continuity of care in psychiatry significantly reduced symptom severity and improved social functioning. The prescriber who reviewed your intake, approved your initial plan, and has access to three months of your daily check-in data is making a different quality of clinical judgment than one who is meeting you for the first time at a follow-up appointment.

What Good Continuity Looks Like in Online Psychiatric Care

Good continuity for an established patient looks like this: you arrive with a medication history, a new platform captures that history comprehensively, a licensed prescriber reviews it and confirms or adjusts your plan based on a full clinical evaluation, and from that point forward there is a structured mechanism for tracking whether the plan is working and responding when it is not.

The key word is "tracking." A prescription renewed without any mechanism to monitor the response is not continuity. It is a refill with a new logo. Continuity means that three months from now, your prescriber knows whether your sleep has improved, whether the anxiety spikes that happened every Sunday have reduced in frequency, and whether the side effect that bothered you in week two resolved or became something you have just been tolerating. That information has to come from somewhere, and it cannot come from a 15-minute appointment every quarter.

This is the exact gap that research on side effect underreporting has documented for decades: physicians systematically underestimate the rate of side effects in their patients because those side effects occur between appointments, not during them. Established patients who have been managing an ongoing side effect silently for months are not a clinical exception. They are a predictable outcome of a monitoring structure that only gathers data at scheduled visits.

Red Flags That Suggest a Platform Is Just Refilling

Not every online platform that accepts established patients is offering genuine continuity. These signs suggest a platform is providing a refill service rather than clinical care:

• The intake is brief and does not ask about your treatment history: If the platform only asks what medication you are currently on and does not explore why, what has changed, and whether it is working, the prescriber does not have the information needed to make a responsible clinical judgment.
• There is no structured between-visit monitoring: If the only mechanism for checking in is to schedule another appointment, the platform is not tracking your medication response. It is waiting for you to flag a problem.
• The first appointment is very short: A complete evaluation of an established patient cannot be done in 10 minutes. If the platform books a short first visit for established patients specifically because they are "just continuing," that framing misunderstands what continuity requires.
• No clinical rationale is offered for continuing your plan: A prescriber who confirms your existing medication without explaining why that medication remains appropriate for your current presentation has not conducted a meaningful evaluation. They have processed a refill.

How SiggyMD Works with Established Patients

SiggyMD does not treat established patients as a shortcut. The intake AI captures your full medication history, your current symptom picture, your prior treatment experience, and your goals, regardless of whether you are starting medication for the first time or arriving with an existing prescription. That history goes to a licensed prescriber who reviews the full clinical summary, the three-condition differential, and the specific considerations that your intake raised before confirming or adjusting your plan.

After your plan is confirmed, the daily check-in structure builds the longitudinal record that makes ongoing care meaningful. Your prescriber is not working from memory or reconstruction at each follow-up. They have structured data on how your symptoms have tracked since you started, what has shifted, and where patterns worth clinical attention have emerged.

Elizabeth Lokenauth, PA-C, of the SiggyMD clinical team, describes what this looks like in practice: "Established patients often come to us having been on the same dose of an antidepressant for two or three years without anyone asking whether it is still the right dose for where they are now. The intake process gives us a real clinical baseline. What we do from that point is actual monitoring, not just waiting for the next appointment."

For patients who are stable on their current medication and want to continue it, the evaluation confirms that the plan is appropriate and builds the monitoring structure that makes that stability sustainable. For patients whose medication is working partially but not fully, or where side effects have gone unaddressed, the evaluation surfaces the clinical picture that a simple refill would have hidden.

The goal is not to make transitions complicated. It is to make them clinically sound. You should arrive at a new platform with your history intact, not start over, but also not receive a rubber stamp on a plan that no one has genuinely reviewed.

What Members Are Saying

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.

Frequently Asked Questions

Can I Start Online Psychiatric Care If I'm Already on Medication?

Yes. Most people who are stable on a current psychiatric medication can transition to online psychiatric care. The transition requires that the new prescriber conduct a full clinical evaluation, not just confirm your existing prescription. This evaluation covers your medication history, current symptom response, any unresolved side effects, and whether the current plan is appropriate for your current clinical presentation. Most people who arrive already on medication leave the evaluation with their plan confirmed and a monitoring structure in place. Some benefit from dose adjustments or other modifications that the intake surfaces.

Will the New Provider Just Continue My Prescription, or Do They Need to Evaluate Me?

Responsible online psychiatric care requires a clinical evaluation before confirming any prescription, including one you are already on. The APA holds telepsychiatry to the same standard as in-person care, which requires a thorough examination and the establishment of a patient-physician relationship before prescribing. A prescriber who confirms your prescription without reviewing your current clinical picture is not practicing responsibly. This evaluation does not mean starting over. It means making sure the plan you are continuing is still appropriate for who you are now.

What If My Medication Is Working? Do I Still Need an Evaluation?

Yes. "Working" is a clinical judgment that requires current clinical data, not just a report that things seem fine. Your symptom response may have shifted since your dose was established. Side effects that were present at the start may have changed. Life circumstances that affect your treatment may be different. A new prescriber who confirms your plan without reviewing these factors is not making a clinical judgment about your current situation. They are accepting a description of your situation at face value. That is not the same thing.

How Does Online Psychiatric Care Handle Medication Continuity During the Transition?

In well-structured platforms, the intake captures your full medication history, including your current prescription, dose, duration, and response. The prescriber reviews this before your plan is confirmed. Most responsible platforms have a mechanism to bridge your prescription during the evaluation period so you are not without medication while the clinical review is completed. Ask any platform you consider how they handle prescriptions during the transition period, and what the timeline looks like from intake to your first prescription.

Can Online Psychiatrists Prescribe the Same Medications My Previous Prescriber Did?

For most psychiatric medications, yes. Licensed psychiatrists and prescribers can prescribe SSRIs, SNRIs, and most non-controlled psychiatric medications through telehealth platforms. Controlled substances, including benzodiazepines and stimulants for ADHD, are subject to additional federal and state regulations and may require different processes. If your current treatment includes a controlled substance, ask the platform specifically how they handle that medication before you assume it can be continued online without additional steps.

What Happens If I Want to Change My Medication After Switching to Online Care?

Medication changes, including dose adjustments, switches to a different antidepressant, or additions to your current regimen, are within the scope of online psychiatric care for most patients. The prescriber who reviewed your intake and has access to your ongoing monitoring data is positioned to make these decisions with better real-time information than a prescriber who sees you quarterly and works from memory. You should not need to restart the evaluation process to request a medication adjustment. That is a clinical conversation your prescriber can have with your longitudinal record in front of them.

Bottom Line

If you are already on psychiatric medication and considering online care, the right question is not "will they just continue my prescription?" It is "will they actually evaluate whether my current plan is right, and will they monitor whether it stays right?"

A refill without evaluation is not continuity. It is a gap in care with a prescription attached. What established patients deserve, and what genuine online psychiatric care provides, is a clinical team that reviews your history, confirms or adjusts your plan based on your current clinical picture, and then builds a monitoring structure that catches what a quarterly snapshot appointment cannot.

You should not have to retell your story every time you see someone new. And your care team should not be working from your description of what is happening. They should be working from the data. That is what continuity actually means.

Sources

1. Semahegn A, et al. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Systematic Reviews. 2020;9(1).
2. Substance Abuse and Mental Health Services Administration. 2024 National Survey on Drug Use and Health (NSDUH). July 2025.
3. American Psychiatric Association. What Is Telepsychiatry? APA Patient Resources. Accessed May 2026.
4. de Cruppé W, et al. Association between continuity of care and treatment outcomes in psychiatric patients in Germany: a prospective cohort study. BMC Psychiatry. 2023;23(1).
5. Dzubur E, et al. The Effect of a Digital Mental Health Program on Anxiety and Depression Symptoms: Retrospective Analysis of Clinical Severity. JMIR Formative Research. 2023;7:e36596.
6. Ferguson JM. SSRI Antidepressant Medications: Adverse Effects and Tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1):22-27.
7. Adler J, Van Brunt D. It is Time to Realize the Promise of the Digital Mental Health Transformation. J Med Internet Res. 2025;27:e63791.
8. Brunt TJ, Gale-Grant O. Telepsychiatry: what clinicians need to know about digital mental healthcare. BJPsych Advances. 2022;29(4):230-238.